The Light-activated Effect of Natural Anthraquinone Parietin against Candida auris and Other Fungal Priority Pathogens
Planta Medica · 01.06.2024 · 90 (07/08) · 588-594
DOI: 10.1055/a-2249-9110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.06.2024. Verfasst von Johannes Fiala und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Austria. Hauptthemen laut MEDLINE: Antifungal Agents, Cryptococcus neoformans, Microbial Sensitivity Tests. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Austrian Science Fund.
Abstract (Originalsprache)
Antimicrobial photodynamic therapy (aPDT) is an evolving treatment strategy against human pathogenic microbes such as the Candida species, including the emerging pathogen C. auris. Using a modified EUCAST protocol, the light-enhanced antifungal activity of the natural compound parietin was explored. The photoactivity was evaluated against three separate strains of five yeasts, and its molecular mode of action was analysed via several techniques, i.e., cellular uptake, reactive electrophilic species (RES), and singlet oxygen yield. Under experimental conditions (λ = 428 nm, H = 30 J/cm2, PI = 30 min), microbial growth was inhibited by more than 90% at parietin concentrations as low as c = 0.156 mg/L (0.55 µM) for C. tropicalis and Cryptococcus neoformans, c = 0.313 mg/L (1.10 µM) for C. auris, c = 0.625 mg/L (2.20 µM) for C. glabrata, and c = 1.250 mg/L (4.40 µM) for C. albicans. Mode-of-action analysis demonstrated fungicidal activity. Parietin targets the cell membrane and induces cell death via ROS-mediated lipid peroxidation after light irradiation. In summary, parietin exhibits light-enhanced fungicidal activity against all Candida species tested (including C. auris) and Cryptococcus neoformans, covering three of the four critical threats on the WHOʼs most recent fungal priority list.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Austria.
- Department of Botany, University of Innsbruck, Austria.
- Leiden Institute of Chemistry, Leiden University, Netherlands.
- Department of Technology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Austria.
- Department of Biotechnology, MCI Innsbruck, Austria.
- Institute of Hygiene und Medical Microbiology, Medical University of Innsbruck, Austria.
ORCID-Profile: Bianka Siewert
Förderung
- Austrian Science Fund
Zitieren
APA
Fiala, J., Roach, T., Holzinger, A., Husiev, Y., Delueg, L., Hammerle, F., Armengol, E. S., Schöbel, H., Bonnet, S., Laffleur, F., Kranner, I., Lackner, M., & Siewert, B. (2024). The Light-activated Effect of Natural Anthraquinone Parietin against Candida auris and Other Fungal Priority Pathogens. Planta Medica, 90(07/08), 588-594. https://doi.org/10.1055/a-2249-9110
Vancouver
Fiala J, Roach T, Holzinger A, Husiev Y, Delueg L, Hammerle F, et al. The Light-activated Effect of Natural Anthraquinone Parietin against Candida auris and Other Fungal Priority Pathogens. Planta Medica. 2024;90(07/08):588-594. doi:10.1055/a-2249-9110
BibTeX
@article{Fiala2024,
author = {Fiala, Johannes and Roach, Thomas and Holzinger, Andreas and Husiev, Yurii and Delueg, Lisa and Hammerle, Fabian and Armengol, Eva Sanchez and Schöbel, Harald and Bonnet, Sylvestre and Laffleur, Flavia and Kranner, Ilse and Lackner, Michaela and Siewert, Bianka},
title = {The Light-activated Effect of Natural Anthraquinone Parietin against Candida auris and Other Fungal Priority Pathogens},
journal = {Planta Medica},
year = {2024},
volume = {90},
number = {07/08},
pages = {588--594},
doi = {10.1055/a-2249-9110}
}
EUVIMED